DLHC vs EML

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 04, 2026

DLHC

45.0
AI Score
VS
DLHC Wins

EML

35.1
AI Score

Investment Advisor Scores

DLHC

45score
Recommendation
HOLD

EML

35score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric DLHC EML Winner
Forward P/E 17.452 9.6061 EML
PEG Ratio 1.1263 1.1538 DLHC
Revenue Growth -46.9% -11.9% EML
Earnings Growth -75.0% 67.7% EML
Tradestie Score 45.0/100 35.1/100 DLHC
Profit Margin -8.5% 3.4% EML
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

DLHC 1M: -12.9% · 3M: -24.7% EML 1M: +25.2% · 3M: +19.7%

Current Technical Phase

DLHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 38

RSI (14): 37.9 · Price: $3.51

EML

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 66

RSI (14): 65.5 · Price: $30.41

Fundamentals Snapshot

Metric DLHC EML
Market Cap — —
Forward P/E -5.1 9.6
Trailing P/E — 25.6
Revenue (TTM) — —
Revenue Growth -0.5% -0.1%
Gross Margin 0.2% 0.2%
Operating Margin -0.1% 0.0%
EPS -1.49 1.15
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, DLHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.